Cargando…

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice

Objective: Based on the 4D label-free phosphoproteomic technique, we examined the differences in cognitive function and hippocampal phosphorylated protein expression in high-fat diet-induced obese mice after the intervention of semaglutide and empagliflozin, as well as the effects of both on protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiaoyi, Chen, Shuchun, Li, Zelin, Zhu, Ruiyi, Jia, Zhuoya, Ban, Jiangli, Zhen, Ruoxi, Chen, Xing, Pan, Xiaoyu, Ren, Qingjuan, Yue, Lin, Niu, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063902/ https://www.ncbi.nlm.nih.gov/pubmed/37007007 http://dx.doi.org/10.3389/fphar.2023.975830

Ejemplares similares

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
por: Chen, Xing, et al.
Publicado: (2022)

Effect of high-fat diet and empagliflozin on cardiac proteins in mice
por: Pan, Xiaoyu, et al.
Publicado: (2022)

UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice
por: Yue, Lin, et al.
Publicado: (2022)

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism
por: Ren, Qingjuan, et al.
Publicado: (2022)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
por: Pan, Xiaoyu, et al.
Publicado: (2023)

The Relationship Between Non-HDL-C /HDL-C Ratio (NHHR) and Vitamin D in Type 2 Diabetes Mellitus
por: Zhen, Ruoxi, et al.
Publicado: (2023)

Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy
por: Ban, Jiangli, et al.
Publicado: (2023)

Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice
por: Zhu, Ruiyi, et al.
Publicado: (2023)

Association Between Vitamin D Levels and the Atherogenic Index of Plasma Among Chinese with Type 2 Diabetes Mellitus
por: Ban, Jiangli, et al.
Publicado: (2023)

Effect of empagliflozin on cytoskeletal repair in the hippocampus of obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2022)

Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023)

The Correlation Between Estimated Glucose Disposal Rate and Coagulation Indexes in Type 2 Diabetes Mellitus
por: Li, Zelin, et al.
Publicado: (2022)

Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy
por: Chen, Xing, et al.
Publicado: (2022)

Correlation of Obesity and Overweight with Cervical Vascular Function Among Healthy Populations
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Correlation between Cardiac Ultrasound Index and Cardiovascular Risk in Healthy Obese and Overweight Populations
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes
por: Reppo, Ingrid, et al.
Publicado: (2023)

Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study
por: Pan, Xiaoyu, et al.
Publicado: (2022)

The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice
por: Wang, Fei, et al.
Publicado: (2020)

The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
por: Malkin, Samuel J. P., et al.
Publicado: (2022)

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
por: Li, Ting, et al.
Publicado: (2021)

Efficacy and Safety of Subcutaneous and Oral Semaglutide Administration in Patients With Type 2 Diabetes: A Meta-Analysis
por: Zhong, Ping, et al.
Publicado: (2021)

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
por: Gao, Xueqin, et al.
Publicado: (2022)

Water-Soluble Tomato Extract Fruitflow Alters the Phosphoproteomic Profile of Collagen-Stimulated Platelets
por: Zhang, Shenghao, et al.
Publicado: (2021)

The Combination of Remnant Cholesterol and Waist Circumference Offers Predictive Value for Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Medical Examination Center
por: Jia, Zhuoya, et al.
Publicado: (2023)

Dapagliflozin versus empagliflozin in patients with chronic kidney disease
por: Alnsasra, Hilmi, et al.
Publicado: (2023)

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark
por: Ehlers, Lars H., et al.
Publicado: (2022)

Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats
por: Aranäs, Cajsa, et al.
Publicado: (2023)

Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies
por: Zhai, Ruonan, et al.
Publicado: (2022)

Phosphoproteomic and proteomic profiling in post-infarction chronic heart failure
por: Wang, Jiayue, et al.
Publicado: (2023)

Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review
por: Liu, Jinyu, et al.
Publicado: (2023)

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients
por: Wang, Dong-Dong, et al.
Publicado: (2022)

Abstract 25: Glycemic variability of oral semaglutide versus empagliflozin: A post hoc analysis of PIONEER 2
por: Shabeer, D, et al.
Publicado: (2022)

Exploring the Appropriate Price of Semaglutide for Type 2 Diabetes Patients Based on Cost-Utility Analysis in China
por: Hu, Shanshan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vkte59ldbb2reen346410o67bu